Phase 1 biotech developing therapies for SCD and hematologic diseases.
Industry: Health Care
First Day Return: +95.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/29/2020 |
Offer Price | $20.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 13.9 |
Deal Size ($mm) | $278 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/18/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $278 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Watertown, MA, United States |
Founded | 2007 |
Employees at IPO | 77 |
Website www.formatherapeutics.com |